Literature DB >> 11479394

Response of catatonia to risperidone: two case reports.

A Valevski1, T Loebl, T Keren, L Bodinger, A Weizman.   

Abstract

The present study describes two patients, both of Yemenite origin, with catatonic schizophrenia who responded to treatment with risperidone. One had a long history of psychiatric disorder, whereas the other was a first-episode, drug-naive patient. Our observation agrees with previous reports on the use of risperidone and other novel neuroleptic agents in the treatment of catatonia of different etiologies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479394     DOI: 10.1097/00002826-200107000-00006

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  6 in total

1.  Falling in and out of consciousness: catatonia in a postoperative patient.

Authors:  David O'Regan; Kathie Wong; Irene Bouras; Carole Foot; Timothy Wigmore
Journal:  J R Soc Med       Date:  2010-03       Impact factor: 5.344

2.  Catatonia associated with initiating paliperidone treatment.

Authors:  Nathanael J McKeown; James H Bryan; B Zane Horowitz
Journal:  West J Emerg Med       Date:  2010-05

3.  High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure.

Authors:  Megan K Skelly; Tammie Lee Demler; Claudia Lee
Journal:  Innov Clin Neurosci       Date:  2019-07-01

Review 4.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

5.  Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms.

Authors:  Juan Pablo Lucchelli; Stamatia Kourakou; Laia Pérez de Lucia Bové; Daniel Diaz Rodriguez
Journal:  Case Rep Psychiatry       Date:  2020-04-03

6.  Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients.

Authors:  Bunta Yoshimura; Tomoya Hirota; Manabu Takaki; Yoshiki Kishi
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-10       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.